13F-HR filed by Ally Bridge Group (NY) LLC
Ally Bridge Group (NY) LLC filed this 13F-HR for the quarter ended 2021-06-30, filed 2021-08-16, with 29 holding rows worth $402,525,000.
- Accession
- 0000950123-21-011101
- Filer
- CIK 1822947
- Filed
- 2021-08-16
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2021
A holdings report, 29 entries on the cover page, a total value of $402,525,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $402,525,000 with VALUE read as thousands by filing date, 13F file number 028-20834. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerFan Yu 028-20833
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| MEDAVAIL HOLDINGS INC | 58406B103 | COM | 2,920,780 | $35,780,000 | thousands by filing date | |
| SPDR SERIES TRUST | 78464A950 | PUT | 200,000 | $27,080,000 | thousands by filing date | put |
| NATERA INC COM | 632307104 | Stock | 218,000 | $24,750,000 | thousands by filing date | |
| FATE THERAPEUTICS INC | 31189P102 | COM | 270,000 | $23,433,000 | thousands by filing date | |
| APELLIS PHARMACEUTICALS INC | 03753U906 | CALL | 300,000 | $18,960,000 | thousands by filing date | call |
| SYROS PHARMACEUTICALS INC | 87184Q107 | COM | 3,439,895 | $18,747,000 | thousands by filing date | |
| ARVINAS INC | 04335A105 | COM | 240,000 | $18,480,000 | thousands by filing date | |
| CEREVEL THERAPEUTICS HLDNG I | 15678U128 | COM | 675,670 | $17,311,000 | thousands by filing date | |
| REPLIGEN CORP COM | 759916109 | Stock | 82,500 | $16,469,000 | thousands by filing date | |
| NUVATION BIO INC COM CL A | 67080N101 | Stock | 1,708,091 | $15,902,000 | thousands by filing date | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 859,910 | $15,728,000 | thousands by filing date | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 95,000 | $15,345,000 | thousands by filing date | |
| NAUTILUS BIOTECHNOLOGY INC | 63909J108 | COM | 1,500,000 | $15,150,000 | thousands by filing date | |
| INTELLIA THERAPEUTICS INC | 45826J105 | COM | 93,127 | $15,078,000 | thousands by filing date | |
| CYTEIR THERAPEUTICS INC | 23284P103 | COMMON | 626,843 | $13,414,000 | thousands by filing date | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 1,622,591 | $13,159,000 | thousands by filing date | |
| NANOSTRING TECHNOLOGIES INC | 63009R109 | COM | 185,000 | $11,986,000 | thousands by filing date | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 510,407 | $10,713,000 | thousands by filing date | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 406,986 | $10,590,000 | thousands by filing date | |
| ESSA PHARMA INC | 29668H708 | COM NEW | 363,185 | $10,376,000 | thousands by filing date | |
| INVITAE CORP | 46185L103 | COM | 300,000 | $10,119,000 | thousands by filing date | |
| GOSSAMER BIO INC COM | 38341P102 | Stock | 1,175,000 | $9,541,000 | thousands by filing date | |
| ATEA PHARMACEUTICALS INC | 04683R106 | COMMON STOCK | 373,288 | $8,018,000 | thousands by filing date | |
| BOLT BIOTHERAPEUTICS INC | 097702104 | COM | 412,267 | $6,374,000 | thousands by filing date | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 85,000 | $5,372,000 | thousands by filing date | |
| ADICET BIO INC | 007002108 | COM | 425,000 | $4,373,000 | thousands by filing date | |
| ARS PHARMACEUTICALS INC | 82835W108 | COM | 128,572 | $3,972,000 | thousands by filing date | |
| FREELINE THERAPEUTICS HLDGS | 35655L107 | SPONSORED ADS | 401,747 | $3,274,000 | thousands by filing date | |
| MACROGENICS INC | 556099109 | COM | 112,839 | $3,031,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000950123-21-011101 | this filing | 2021-08-16 | acceptance time not in the bulk data set |